John Prendergast
Founder at PALATIN TECHNOLOGIES, INC.
Net worth: 229 345 $ as of 29/04/2024
John Prendergast active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Founder | 20/11/1986 | - |
| Chairman | 13/06/2000 | - | |
| Independent Dir/Board Member | 20/11/1986 | - | |
| Director/Board Member | 31/07/1996 | 13/06/2000 | |
| SCORPIUS HOLDINGS, INC. | Director/Board Member | 25/04/2016 | - |
| Independent Dir/Board Member | 25/04/2016 | - | |
| RECCE PHARMACEUTICALS LTD | Independent Dir/Board Member | 23/04/2018 | - |
| Chairman | 08/07/2019 | - | |
| Director/Board Member | 23/04/2018 | 08/07/2019 | |
| SummerCloud Bay, Inc. | President | 31/12/1992 | - |
Ingenex, Inc.
 Ingenex, Inc. BiotechnologyHealth Technology Part of Titan Pharmaceuticals, Inc., Ingenex, Inc. is a company based in San Francisco, CA. | Director/Board Member | - | - |
| Nejo, Inc. | Chairman | - | - |
| Founder | - | - | |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - |
Career history of John Prendergast
Former positions of John Prendergast
| Companies | Position | Start | End |
|---|---|---|---|
| AVAX TECHNOLOGIES, INC. | Chief Executive Officer | 20/10/2011 | 31/12/2012 |
| Chairman | 30/06/1996 | 31/12/2012 | |
| MEDICINOVA, INC. | Director/Board Member | 31/08/2004 | 24/09/2011 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | - | - | |
| ░░░░░░░ | - | - |
Training of John Prendergast
| Harvard University | Masters Business Admin |
| The University of New South Wales | Doctorate Degree |
Statistics
International
| United States | 13 |
| Australia | 3 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 8 |
| Chairman | 5 |
| Chief Executive Officer | 4 |
Sectoral
| Health Technology | 10 |
| Consumer Services | 3 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| MEDICINOVA, INC. | Health Technology |
| SCORPIUS HOLDINGS, INC. | Health Technology |
| RECCE PHARMACEUTICALS LTD | Health Technology |
| Private companies | 9 |
|---|---|
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
Ingenex, Inc.
Ingenex, Inc. BiotechnologyHealth Technology Part of Titan Pharmaceuticals, Inc., Ingenex, Inc. is a company based in San Francisco, CA. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Castle Group Ltd.
 Castle Group Ltd. Real Estate DevelopmentFinance Part of Places for People Group Ltd., Castle Group Ltd. is a holding British company with interests in residential property management and portable appliance testing. The company is based in Scarborough, UK. Castle Group was acquired by Paladin Group Ltd. on July 14, 2006 for $14.74 million. | Finance |
| SummerCloud Bay, Inc. | |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Health Technology |
| Paramount Capital Investments LLC | |
| Nejo, Inc. | |
Osaka Exchange, Inc.
 Osaka Exchange, Inc. Investment Banks/BrokersFinance Osaka Exchange, Inc. provides markets for index futures, index options, and security options. It also conducts the administration of trading, the administration of transaction participants, and the development and investigative research for new products and trading frameworks. The company was founded on April 1, 1949 and is headquartered in Osaka, Japan. | Finance |
- Stock Market
- Insiders
- John Prendergast
- Experience
